文献速递产科母胎医学

妊娠期高血压疾病与胎儿生长受限孕妇妊娠期及产后的母体血流动力学特征

Maternal hemodynamic profile during pregnancy and in the post-partum in hypertensive disorders of pregnancy and fetal growth restriction.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-12-21

前瞻性纵向病例对照研究纳入220例单胎孕妇,分四组比较妊娠期及产后经胸超声心动图血流动力学。妊娠期高血压疾病合并胎儿生长受限组心输出量降低并出现左室向心性重构;产后随访104例,该组及单纯胎儿生长受限组血流动力学恢复至对照水平,但17%存在无症状B期心力衰竭。妊娠期高血压疾病且胎儿适于胎龄组产后平均动脉压、总血管阻力及左室质量仍显著高于对照。

要点

  • 妊娠期高血压疾病合并胎儿生长受限者妊娠期心输出量降低、左室向心性重构,产后血流动力学恢复至对照水平。
  • 妊娠期高血压疾病且胎儿适于胎龄者产后平均动脉压、总血管阻力及左室质量仍显著高于对照。
  • 妊娠期高血压疾病合并胎儿生长受限组及单纯胎儿生长受限组仅8.3%产后仍患高血压,17%超声心动图见无症状B期心力衰竭。

核心结论

  • 妊娠期高血压疾病合并胎儿生长受限及血压正常合并胎儿生长受限的妊娠表现为心率及心输出量降低的血流动力学特征,最可能因妊娠适应异常所致,并由妊娠至产后的异常变化所证实。
  • 妊娠期高血压疾病且胎儿适于胎龄组的心率及心输出量变化方向与妊娠期高血压疾病合并胎儿生长受限组及胎儿生长受限组相反。
  • 肥胖及其他代谢危险因素在妊娠期高血压疾病且胎儿适于胎龄组显著多见,易患妊娠期及产后高血压和心血管疾病,可能提供个体化预防的窗口。

研究设计与样本

  • 前瞻性纵向病例对照研究,研究期间选取220例符合条件的单胎妊娠孕妇进行分析,分为4组:妊娠期高血压疾病且胎儿适于胎龄组、妊娠期高血压疾病合并胎儿生长受限组、血压正常合并胎儿生长受限组及对照组。
  • 招募时行超声胎儿生物测量及胎儿胎盘多普勒测速,并由对母体临床数据设盲的专职心脏科医师行经胸超声心动图母体血流动力学评估。
  • 产后32周(四分位距24-40周)由同一心脏科医师对104例患者重复相同评估。

主要发现

  • 妊娠期,妊娠期高血压疾病合并胎儿生长受限组心输出量显著低于对照组,并伴左室向心性重构(相对室壁厚度增加而左室质量未增加)。
  • 单纯胎儿生长受限组呈现相似但程度较轻的血流动力学变化,但相对室壁厚度无变化。
  • 产后随访时,妊娠期高血压疾病合并胎儿生长受限组及单纯胎儿生长受限组血流动力学参数恢复至与对照组相似的水平;这些组中仅8.3%产后仍患高血压,17%超声心动图见无症状B期心力衰竭。
  • 妊娠期高血压疾病且胎儿适于胎龄组心输出量如正常妊娠一样增加,但总血管阻力显著更高,随后出现高血压并伴心室向心性肥厚及舒张功能障碍。
  • 产后随访时,妊娠期高血压疾病且胎儿适于胎龄组平均动脉压、总血管阻力及左室质量显著高于对照组;该组持续高血压及无症状B期心力衰竭分别见于39.1%和13%的妇女。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Maternal cardiovascular changes, occurring since the beginning of pregnancy, are necessary for normal placentation and regular evolution of pregnancy. OBJECTIVE: This study aimed to compare the hemodynamic profiles and cardiac remodeling of women with hypertensive disorders of pregnancy and either appropriate for gestational age fetuses or growth-restricted fetuses, women with normotensive pregnancies complicated by fetal growth restriction, and women with uncomplicated pregnancies, during pregnancy and the postpartum period. STUDY DESIGN: A prospective longitudinal case-control design was used for this study. Over the study period, 220 eligible women with singleton pregnancies were selected for the analysis and divided into 4 groups: (1) hypertensive disorders of pregnancy with appropriate for gestational age fetuses; (2) hypertensive disorders of pregnancy with fetal growth restriction; (3) normotensive fetal growth restriction; and (4) controls. Ultrasound fetal biometry and fetoplacental Doppler velocimetry were performed at recruitment. Maternal hemodynamic assessment using transthoracic echocardiography was performed at the time of recruitment by a dedicated cardiologist blinded to maternal clinical data. The same assessments were performed in 104 patients at 32 weeks (interquartile range, 24-40) after delivery by the same cardiologist. RESULTS: During pregnancy, women in the hypertensive-disorders-of-pregnancy-fetal-growth-restriction group showed significantly lower cardiac output and increased compared with those in the control group. These values were associated with concentric remodeling of the left ventricle owing to relatively increased wall thickness, which was not accompanied by an increase in left ventricular mass. Isolated fetal growth restriction presented similar but less important hemodynamic changes; however, there was no change in relative wall thickness. At postpartum follow-up, the hemodynamic parameters of women in the hypertensive-disorders-of-pregnancy-fetal-growth-restriction and isolated-fetal-growth-restriction groups reverted to values similar to those of the control group. Only 8.3% of women in these groups experienced hypertension even in the postpartum period, and asymptomatic stage-B cardiac failure was observed for 17% at echocardiography. In the group of women with hypertensive disorders of pregnancy and appropriate for gestational age fetuses, cardiac output increased as in normal pregnancies, but total vascular resistance was significantly higher; hypertension then occurred, along with ventricular concentric hypertrophy and diastolic dysfunction. At postpartum follow-up, women in the hypertensive-disorders-of-pregnancy-appropriate-for-gestational-age-fetus group showed significantly higher mean arterial pressure, total vascular resistance, and left ventricular mass compared with those in the control group. Persistent hypertension and asymptomatic stage-B cardiac failure were observed in 39.1% and 13% of women in the former group, respectively. CONCLUSION: Pregnancies with hypertensive disorders of pregnancy and fetal growth restriction and normotensive pregnancies with fetal growth restriction were associated with the hemodynamic profile of lower heart rate and cardiac output, most likely because of abnormal adaptation to pregnancy, as confirmed by abnormal changes from pregnancy to the postpartum period. The heart rates and cardiac output of women in the hypertensive-disorders-of-pregnancy-appropriate-for-gestational-age-fetus group showed changes opposite to those observed in the hypertensive-disorders-of-pregnancy-fetal-growth-restriction and fetal-growth-restriction groups. Obesity and other metabolic risk factors, significantly prevalent in women in the hypertensive-disorders-of-pregnancy-appropriate-for-gestational-age-fetus group, predispose to hypertension and cardiovascular diseases during pregnancy and the postpartum period, potentially offering a window for personalized prevention. Such preventive strategies could differ in women with hypertensive disorders of pregnancy and fetal growth restriction characterized by poor early placental development.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Di Martino DD, Stampalija T, Zullino S, et al. Maternal hemodynamic profile during pregnancy and in the post-partum in hypertensive disorders of pregnancy and fetal growth restriction. Am J Obstet Gynecol MFM. 2022. PMID: 36563878. doi:10.1016/j.ajogmf.2022.100841

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。